Difficult-to-treat resistance, not carbapenem non-susceptibility, is associated with 30-day mortality in respiratory gram-negative bacilli: a 12-year surveillance cohort
Frontiers in Cellular and Infection Microbiology · 20.07.2026 · 16
DOI: 10.3389/fcimb.2026.1871310 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 20.07.2026. Verfasst von Yahya Shabi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia. Hauptthemen laut MEDLINE: Carbapenems, Anti-Bacterial Agents, Gram-Negative Bacterial Infections, Gram-Negative Bacteria. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deanship of Scientific Research, King Khalid University.
Abstract (Originalsprache)
Objectives
Antimicrobial resistance in respiratory gram-negative bacilli (GNB) is rising in Saudi Arabia, yet the clinical impact of difficult-to-treat resistance (DTR) remains poorly defined. We characterized temporal trends in organism distribution, non-susceptibility phenotypes, and their association with 30-day in-hospital mortality.
Methods
Retrospective cohort of hospitalized patients aged ≥12 years with culture-positive respiratory GNB at a referral hospital in southern Saudi Arabia (January 2013–August 2024). Non-susceptibility phenotypes were fluoroquinolone (FQ-NS), extended-spectrum cephalosporin (ESC-NS), carbapenem non-susceptibility, and DTR. Trends were assessed with segmented binomial regression, mortality with modified Poisson regression.
Results
Among 6,999 isolate-episodes from 3,808 patients, Enterobacterales (57.2%) increased while non-fermenting GNB declined (AAPC, −2.5%). Carbapenem non-susceptibility rose among Enterobacterales (AAPC, + 5.4%), driven by Klebsiella pneumoniae . DTR was 37.6%, rising in Enterobacterales (AAPC, + 12.1%) but declining in Acinetobacter baumannii . Thirty-day mortality was 27.9%. DTR was associated with mortality in Enterobacterales (aRR, 1.34; 95% CI, 1.16–1.55) and non-fermenting GNB (aRR, 1.28; 95% CI, 1.12–1.46); carbapenem non-susceptibility without DTR was not. Mortality rose as active first-line agents decreased ( P -trend<.001).
Conclusions
Respiratory GNB epidemiology is shifting toward Enterobacterales with rising resistance. DTR, not carbapenem non-susceptibility alone, was consistently associated with 30-day mortality and provides a meaningful framework for risk stratification and resistance-centered surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Clinical Parasitology, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Department of Pulmonology, Aseer Central Hospital, Abha, Saudi Arabia.
- Department of Medicine, College of Medicine, King Khalid University, Abha, Saudi Arabia.
- Department of Pathology, College of Medicine, King Saud University and King Saud University Medical City, Riyadh, Saudi Arabia.
- Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
- Internal Medicine Residency Program, Aseer Central Hospital, Abha, Saudi Arabia.
Förderung
- Deanship of Scientific Research, King Khalid University
Zitieren
APA
Shabi, Y., Alwadei, N., Alshahrani, M., Somily, A. M., Binkhamis, K., Asiri, E., Mohamed, S., Bawazeer, A. O. S., Al Oudhah, S. M., Alqahtani, R. A., Alhamlan, R., Salem, E., Al Ghamdi, B., Habtar, G., Alqahtani, A., Asiri, F., Jali, M., Almahdi, H., & Alahmari, H. (2026). Difficult-to-treat resistance, not carbapenem non-susceptibility, is associated with 30-day mortality in respiratory gram-negative bacilli: a 12-year surveillance cohort. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1871310
Vancouver
Shabi Y, Alwadei N, Alshahrani M, Somily AM, Binkhamis K, Asiri E, et al. Difficult-to-treat resistance, not carbapenem non-susceptibility, is associated with 30-day mortality in respiratory gram-negative bacilli: a 12-year surveillance cohort. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1871310
BibTeX
@article{Shabi2026,
author = {Shabi, Yahya and Alwadei, Nawal and Alshahrani, Mona and Somily, Ali M and Binkhamis, Khalifa and Asiri, Elham and Mohamed, Soliuman and Bawazeer, Abdulah O S and Al Oudhah, Saud Mushabbab and Alqahtani, Rawan Abdullah and Alhamlan, Rawan and Salem, Eman and Al Ghamdi, Basma and Habtar, Ghadah and Alqahtani, Amal and Asiri, Fatimah and Jali, Mazen and Almahdi, Hussein and Alahmari, Hana},
title = {Difficult-to-treat resistance, not carbapenem non-susceptibility, is associated with 30-day mortality in respiratory gram-negative bacilli: a 12-year surveillance cohort},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1871310}
}
EUVIMED